In April, the most popular stories from Interventional News included highlight research from the Society of Interventional Radiology (SIR) annual scientific meeting (23–28 March, Salt Lake City, USA); Andrew Holden (Auckland City Hospital; University of Auckland, Auckland, New Zealand) shares his thoughts on the paclitaxel mortality controversy ahead of the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK); and new research which finds early DAPT, statin therapy and stent patency are among predictors of good post-thrombectomy outcomes, among several others.
AngioDynamics has announced that the US Food and Drug Administration (FDA) has cleared the AlphaVac F1885 system for the treatment of pulmonary embolism (PE), enhancing its utility in critical medical scenarios such as PE.
2. EMBOLIZE trial launched to rectify unmet need in treatment of chronic pelvic pain
The EMBOLIZE trial, a prospective, randomised controlled trial—the first of its kind—was recently launched at the Society of Interventional Radiology (SIR) annual scientific meeting (23–28 March, Salt Lake City, USA), and seeks to investigate the effects of ovarian vein embolization (OVE) and pelvic vein embolization in reducing symptoms in women experiencing chronic pelvic pain due to pelvic venous disease (PeVD).
3. Striving for excellence: Bien Soo Tan awarded SIR 2024 Gold Medal
Hotly debated across SIO annual conference programme, speakers took to the stage to contest the survival of transarterial chemoembolization (TACE) in the age of yttrium-90 (Y90) transarterial radioembolization (TARE) and immunotherapy, their compelling arguments making some audience members “more confused and others happy”.
4. EMBOLIZE pelvic venous disease study launched at SIR 2024
The Society of Interventional Radiology (SIR) Foundation, The VIVA Foundation and Penumbra, today announced the launch of the EMBOLIZE trial, a first-of-its-kind prospective, randomised controlled trial studying the effects of ovarian vein embolization (OVE) and pelvic vein embolization in reducing pain in women experiencing chronic pelvic pain due to pelvic venous disease (PeVD).
5. Striving for excellence: Bien Soo Tan awarded SIR 2024 Gold Medal
Bien Soo Tan is a senior consultant at the Department of Vascular and Interventional Radiology (IR) at Singapore General Hospital (SGH). Following his recent acceptance of the Society of Interventional Radiology (SIR) Gold Medal award, Tan speaks to Interventional News about his achievements to date.
6. Cerenovus launches aspiration catheter for treatment of acute ischaemic stroke
Cerenovus, part of Johnson & Johnson MedTech, has today announced the launch of Cereglide 71 aspiration catheter in Europe, an aspiration catheter equipped with TruCourse technology, indicated for the revascularisation of patients suffering from acute ischemic stroke.
New research to be presented at the Society of Interventional Radiology (SIR) annual scientific meeting has found early intervention with uterine artery embolization (UAE) can help women avoid hysterectomy due to severe bleeding after childbirth.
8. New data and heated debates set to spark controversy in CX 2024 peripheral arterial programme
“These will be important, salutary lessons. Should a controversy arise again involving a proven efficacious therapy, we now know that stopping access to that therapy may result in unwanted and unexpected negative effects on patient care.” These are the preluding thoughts of Andrew Holden (Auckland City Hospital; University of Auckland, Auckland, New Zealand)—one of the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK) co-chairs—ahead of this year’s meeting, referencing the paclitaxel mortality controversy.
9. Early DAPT, statin therapy and stent patency among predictors of good post-thrombectomy outcomes
An analysis involving some 300 patients with anterior-circulation acute ischaemic strokes caused by tandem lesions has determined a number of factors that may be predictive of good clinical outcomes at three months following an endovascular mechanical thrombectomy procedure.
10. New data presented by recognised speakers during SIR Best of abstracts session
This year’s Society of Interventional Radiology (SIR) annual scientific meeting (23–28 March, Salt Lake City, USA) gave recognition to select abstracts during the closing plenary session. Introduced by SIR 2024 programme chair Bulent Arslan (Rush University, Chicago, USA), who commended the “strong” and “compelling” presentations, speakers offered data which challenge preconceptions about disease states and treatment strategies.
